Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
IVERIC bio $115.2 million stock offering
We advised the underwriters on the SEC-registered equity offering
Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing
Smartfit R$2.3 billion IPO
The shares trade on the São Paulo Stock Exchange
Zhejiang Expressway $470 million bonds offering
We advised the issuer on the Regulation S offering
Minerva $400 million senior notes offering
We advised the initial purchasers on the Rule 144A / Regulation S notes offering
Salesforce.com $8 billion debt offering
The company intends to use the proceeds in part to fund its acquisition of Slack Technologies
IDEAYA Biosciences $92 million follow-on offering
We advised the underwriters on the SEC-registered stock offering
Mizuho Financial Group $1.75 billion senior notes offering
The offering involved senior callable fixed-to-fixed reset rate notes due 2027 and 2032
Cellnex Telecom $600 million senior notes offering
We advised Cellnex on its offering of senior notes due 2041
Frontier Investment $200 million IPO
We advised the underwriter on the SPAC IPO and Nasdaq listing